A Phase 1b/2 Study of Entospletinib (GS-9973) Monotherapy and in Combination With Chemotherapy in Patients With Acute Myeloid Leukemia (AML)
This study will evaluate the efficacy, safety, tolerability, and pharmacodynamics of
entospletinib (GS-9973) when administered as monotherapy or in combination with chemotherapy
in adults with acute myeloid leukemia (AML).
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society